Panbela Therapeutics Inc Quick Ratio (PBLA) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Panbela Therapeutics Inc   (PBLA)

Panbela Therapeutics Inc 's Quick Ratio

PBLA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Panbela Therapeutics Inc 's Cash & cash equivalent grew by 7911.86 % in the Q3 2024 sequentially, faster than Current Liabilities, this led to improvement in Panbela Therapeutics Inc 's Quick Ratio to 0.23, Quick Ratio remained below Panbela Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry 439 other companies have achieved higher Quick Ratio than Panbela Therapeutics Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 3168 to 3174.

Explain Quick Ratio?
How much Cash & cash equivalents PBLA´s has?
What are PBLA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBLA Quick Ratio (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3
Y / Y Current Liabilities Change 125.88 % 59.05 % 7.93 % 57.26 % 12.14 %
Y / Y Cash & cash equivalent Change 421.17 % -99.18 % -95 % 100.62 % -3.61 %
Quick Ratio MRQ 0.23 0 0.02 0.21 0.1
PBLA's Total Ranking # 3174 # 3168 # 2933 # 2641 # 3517
Seq. Current Liabilities Change 19.98 % 59.6 % -14.6 % 38.14 % -15.52 %
Seq. Cash & cash equivalent Change 7911.86 % -77.48 % -89.84 % 184.23 % -87.41 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 440
Healthcare Sector # 857
Overall Market # 3174


Quick Ratio Statistics
High Average Low
10.51 1.71 0
(Sep 30 2021)   (Jun 30 2024)




Financial Statements
Panbela Therapeutics Inc 's Current Liabilities $ 20 Millions Visit PBLA's Balance sheet
Panbela Therapeutics Inc 's Cash & cash equivalent $ 5 Millions Visit PBLA's Balance sheet
Source of PBLA's Sales Visit PBLA's Sales by Geography


Cumulative Panbela Therapeutics Inc 's Quick Ratio

PBLA's Quick Ratio for the trailling 12 Months

PBLA Quick Ratio

 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 61.31 % 34.52 % 33.33 % 56.78 % 73.79 %
Y / Y Cash & cash equivalent TTM Growth -47.88 % -74.05 % 9.62 % 31.16 % -35.61 %
Quick Ratio TTM 0.13 0.08 0.26 0.38 0.39
Total Ranking TTM # 3526 # 2329 # 2761 # 1997 # 3854
Seq. Current Liabilities TTM Growth 23.12 % 14.73 % 1.86 % 12.1 % 2.67 %
Seq. Cash & cash equivalent TTM Growth 100.37 % -65.25 % -31.23 % 8.84 % -0.23 %

Quick ratio ranking by company, industry and sector >> Back to PBLA Financial Strength Comparisons >> Go to Compare PBLA Quick Ratio to its Competitors

On the trailing twelve months basis PBLA Cash & cash equivalent more than doubled by 421.17 % in Q3 2024 year on year, faster than Current Liabilities, this led to increase in in Panbela Therapeutics Inc 's Quick Ratio to 0.13, Quick Ratio remained below PBLA average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 448 other companies have achieved higher Quick Ratio than Panbela Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 2329 to 3526.

Explain Quick Ratio?
How much Cash & cash equivalents PBLA´s has?
What are PBLA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 449
Healthcare Sector # 942
Within the Market # 3526


trailing twelve months Quick Ratio Statistics
High Average Low
6.95 1.49 0.08
(Sep 30 2021)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2024 MRQ Cash & cash equivalentSep 30 2024 MRQ Current Liabilities
Oculis Holding Ag  0.63 $ 30.556  Millions$ 48.781  Millions
Clene Inc   0.61 $ 14.645  Millions$ 23.828  Millions
Johnson and Johnson  0.61 $ 20,297.000  Millions$ 33,320.000  Millions
Hepion Pharmaceuticals Inc   0.58 $ 1.497  Millions$ 2.598  Millions
Cumberland Pharmaceuticals Inc   0.57 $ 17.465  Millions$ 30.696  Millions
Igc Pharma Inc   0.55 $ 1.546  Millions$ 2.802  Millions
Edesa Biotech Inc   0.55 $ 1.000  Millions$ 1.813  Millions
Akebia Therapeutics Inc   0.52 $ 34.019  Millions$ 65.709  Millions
Durect Corp  0.51 $ 10.376  Millions$ 20.207  Millions
Optinose Inc   0.51 $ 82.497  Millions$ 162.430  Millions
Elanco Animal Health Incorporated  0.50 $ 490.000  Millions$ 988.000  Millions
Merck and Co Inc   0.49 $ 14,593.000  Millions$ 29,586.000  Millions
Vireo Growth Inc.  0.49 $ 7.280  Millions$ 14.802  Millions
Lftd Partners Inc   0.49 $ 3.234  Millions$ 6.598  Millions
Prestige Consumer Healthcare Inc   0.48 $ 51.540  Millions$ 106.906  Millions
Vaccinex Inc   0.47 $ 2.906  Millions$ 6.175  Millions
Bio Green Med Solution Inc   0.47 $ 2.982  Millions$ 6.351  Millions
Scorpius Holdings inc   0.47 $ 4.810  Millions$ 10.336  Millions
Bausch Health Companies Inc   0.46 $ 719.000  Millions$ 1,577.000  Millions
Hyperion Defi inc   0.46 $ 7.188  Millions$ 15.783  Millions
Citius Pharmaceuticals Inc   0.45 $ 3.252  Millions$ 7.156  Millions
Grifols Sa  0.45 $ 1,097.354  Millions$ 2,414.884  Millions
Avid Bioservices Inc   0.45 $ 33.415  Millions$ 74.156  Millions
Biodexa Pharmaceuticals Plc  0.45 $ 2.807  Millions$ 6.303  Millions
Ernexa Therapeutics Inc   0.43 $ 4.264  Millions$ 9.952  Millions
Novartis Ag  0.40 $ 11,592.000  Millions$ 28,692.000  Millions
Stablecoin Development Corporation  0.39 $ 0.776  Millions$ 1.984  Millions
Integrated Biopharma Inc  0.38 $ 2.271  Millions$ 6.029  Millions
Casi Pharmaceuticals inc   0.37 $ 13.468  Millions$ 36.452  Millions
Petros Pharmaceuticals inc   0.36 $ 3.900  Millions$ 10.819  Millions

Date modified: 2026-09-12T06:13:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.